http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102011971-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57449 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate | 2019-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-102011971-B1 |
| titleOfInvention | Biomarkers for the diagnosis of ovarian cancer, indicating differences in expression levels |
| abstract | The present invention relates to a biomarker for diagnosing ovarian cancer and a use thereof. The composition, kit, and method according to one aspect may not only diagnose ovarian cancer, but also based on the gene expression level of ovarian cancer tissue after surgery or treatment. By enabling the prediction of the prognosis, the ovarian cancer patient may be able to receive appropriate prognostic measures. In addition, by securing the gene profiling data of Asian ovarian cancer patients and analyzing the data, it is possible to overcome the problem of predicting the prognosis of ovarian cancer patients, which are made based on the data of conventional Westerners. |
| priorityDate | 2019-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 509.